Immuneel

Bengaluru, India · Founded 2018 · Privately Held (backing)

Developer of a cell therapy intended to provide cell and gene therapies for cancer treatment. Immuneel is based in Bengaluru, India and was founded in 2018. Its last known valuation is $67.9 million. It has raised $38 million.

Last price · $/share
—
Implied valuation
$67.9M
Total raised
$38.0M
Last round
—

Who backs Immuneel?

16 investors
InvestorType
Khosla VenturesVenture capital
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Ranjan PaiHigh net worth
True NorthOther
Apollo Hospitals—
Arun M—
Biogen Idec Foundation—
Dr. Devi Shetty—
Glentec International—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Immuneel investors

16 investors are on record for Immuneel, including Khosla Ventures, F-Prime Capital, Eight Roads and Ranjan Pai.

Free account
More of Immuneel with a free account
  • ·The complete investor list: 16 names
  • ·Watch Immuneel: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Immuneel. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View